|
681
|
|
|
Thyrotropin releasing hormone |
Pro-TRH, TRF |
Alzheimer disease, Amnesia, Cardiac arrhythmias, Bradycardia, Cardiac arrhythmia, Catalepsy, Major depressive disorder, Endometriosis, Hypertension, Learning disorders, Myeloid leukemia, Depression, Narcolepsy, Seizures, Tremor |
|
682
|
|
|
Thyrotropin releasing hormone receptor |
CHNG7, TRH-R |
Androgenetic alopecia, Brachycephaly, Congenital central hypothyroidism, Coronary artery disease, Female infertility, Global developmental delay, Hypertension, Hypothyroidism, Keratitis, Metabolic syndrome, Intellectual disability, Oligodendroglioma, Schizophrenia, Diabetes mellitus, type 2 |
|
683
|
|
|
Trio Rho guanine nucleotide exchange factor |
ARHGEF23, MEBAS, MRD44, MRD63, tgat |
Anaphylaxis, Angioedema, Asthma, Color vision deficiency, Deafness, Developmental delay, Essential tremor, Gout, Intellectual developmental disorder, Myeloid leukemia, Liver neoplasm, Major depressive disorder, Neuroblastoma, Neurodevelopmental disorder, Neurodevelopmental disorders, Neuropathy, Peripheral neuropathy, Prostate cancerView all (3 more) |
|
684
|
|
|
Transient receptor potential cation channel subfamily C member 3 |
SCA41, TRP3 |
|
|
685
|
|
|
Transient receptor potential cation channel subfamily C member 4 |
HTRP-4, HTRP4, TRP4 |
|
|
686
|
|
|
Transient receptor potential cation channel subfamily C member 5 |
PPP1R159, TRP5 |
|
|
687
|
|
|
Transient receptor potential cation channel subfamily C member 6 |
FSGS2, TRP6 |
Alzheimer disease, Cardiac embolism, Cardioembolic stroke, Fatigue syndrome, Colorectal adenoma, Colorectal cancer, Idiopathic steroid-resistant nephrotic syndrome, Focal glomerulosclerosis, Focal segmental glomerulosclerosis, Genetic steroid-resistant nephrotic syndrome, Steroid-resistant nephrotic syndrome, Hypertension, Hypertrophy, Nephrotic syndrome, Kidney disease, Preeclampsia , Scoliosis, Systemic sclerosisView all (3 more) |
|
688
|
|
|
Transient receptor potential cation channel subfamily M member 2 |
EREG1, KNP3, LTRPC2, LTrpC-2, NUDT9H, NUDT9L1, TRPC7 |
|
|
689
|
|
|
Transcriptional repressor GATA binding 1 |
GC79, LGCR |
Alzheimer disease, Androgenetic alopecia, Anorexia nervosa, Attention deficit hyperactivity disorder, Basal cell carcinoma, Bone disease, Brachydactyly, Breast cancer, Congenital anomalies of the kidney and urinary tract, Carcinoma, Obstructive pulmonary disease, Color vision deficiency, Colorectal cancer, Congenital cartilage disorder, Craniofacial abnormalities, Craniosynostosis, Crohn disease, Cutaneous squamous cell carcinoma, Dementia, Desbuquois syndrome, Diabetes mellitus, Diabetic eye disease, Diabetic neuropathy, Diabetic retinopathy, Digestive system disease, Diverticular disease, Eating disorder, Endometriosis, Estrogen-receptor negative breast cancer, Gout, Inflammatory bowel disease, Insomnia, Keratinocyte carcinoma, Major depressive disorder, Intellectual developmental disorder, Metabolic syndrome, Metaphyseal chondrodysplasia, Mitral valve prolapse, Enterocolitis, Neurotic disorder, Non-small cell lung carcinoma, Obesity, Oligodendroglioma, Osteochondrodysplasias, Parkinson disease, Peripheral arterial disease, Schizophrenia, Skin cancer, Skin disease, Skin neoplasm, Squamous cell carcinoma, Trichorhinophalangeal syndrome, Diabetes mellitus, type 2, Ulcerative colitis, Uterine polypView all (40 more) |
|
690
|
|
|
TSC complex subunit 1 |
LAM, TSC |
Autism, Brain disease, Hepatocellular carcinoma, Renal cell carcinoma, Squamous cell carcinoma, Cognition disorder, Cryptogenic west syndrome, Delirium, dementia, and cognitive disorders, Epilepsy, Focal cortical dysplasia, Keratoconus, Intellectual developmental disorder, Mouth neoplasm, Psoriasis, Infantile spasms, Seizures, Tuberous sclerosis complex, West syndromeView all (3 more) |
